{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":" Race and Sex Disparities in Mitral Valve Edge-to-Edge Repair ","description":"In this week\u2019s&amp;nbsp;View,&amp;nbsp;Dr. Eagle highlights a study showing race and sex disparities in M-TEER outcomes, with Black patients presenting with more advanced disease, lower success, and higher heart failure readmissions than White patients, and women having lower success rates than men.&amp;nbsp;He reviews the SOGALDI-PEF trial, where patients with low plasma renin levels experienced greater blood pressure reduction with spironolactone\/dapagliflozin compared to dapagliflozin alone.&amp;nbsp;Next,&amp;nbsp;he&amp;nbsp;discusses the FAVOR III trial, which found that QFR-guided&amp;nbsp;percutaneous coronary intervention&amp;nbsp;improved five-year outcomes versus angiography guidance, with most benefits occurring in the first two years. Lastly,&amp;nbsp;Dr. Eagle&amp;nbsp;examines two renal disease studies addressing&amp;nbsp;optimal&amp;nbsp;chronic kidney disease&amp;nbsp;(CKD)&amp;nbsp;GFR thresholds and the benefits of&amp;nbsp;finerenone&amp;nbsp;in CKD patients.&amp;nbsp; ","author_name":"Eagle's Eye View: Your Weekly CV Update From ACC.org","author_url":"http:\/\/www.acc.org","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/41669135\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/203027720"}